EBR Systems is a Sunnyvale, California medical device company that developed the WiSE System, the world's first and only leadless left ventricular endocardial pacing device for cardiac resynchronization therapy. About the size of a grain of rice, the ultrasound-powered electrode paces the inside of the heart's left ventricle without wires, working alongside a patient's existing pacemaker or defibrillator. After its pivotal SOLVE-CRT trial was halted early for success, the WiSE System won U.S. FDA approval in April 2025 and began its commercial launch for heart failure patients who have run out of conventional options.
Shifamed is a Silicon Valley medical technology incubator founded in 2009 by serial entrepreneur Amr Salahieh. It combines human-centered design, in-house engineering, and R&D facilities to build medical device companies from concept to commercial launch, spinning out and incubating startups across cardiovascular, electrophysiology, and ophthalmology. Its portfolio and legacy companies have raised over $800M and produced multiple acquisitions by Boston Scientific, Abbott, Covidien, and Johnson & Johnson.
Wearlinq is a San Francisco healthtech company building eWave, described as the first continuous, wireless, FDA 510(k)-cleared 6-lead ECG cardiac monitor. About the size of a coin and worn on a skin-like adhesive patch, eWave pairs with a patient's own smartphone, runs 5+ days between charges in an AirPods-style case, and streams near-real-time data so clinicians get hospital-grade multi-lead visibility without the bulk of a wired Holter monitor. The company also operates an IDTF (independent diagnostic testing facility) staffed by certified cardiographic technicians who turn around STAT reports, closing the loop from device to diagnosis.
Arctop is a cognition company building software that decodes the human brain. Its AI platform translates electrical brain-activity signals from everyday wearables - headbands, earbuds, and VR/AR headsets - into real-time, actionable insight about focus, emotion, intention, and memory. Founded in 2016 by neuroscientist Dan Furman and engineer Eitan Kay, Arctop licenses its non-invasive brain-decoding software to developers and enterprises across health, entertainment, education, and government, positioning itself as the intelligence layer between brain-sensing hardware and the applications that use it.
Nventric, Inc. is a medical device company and contract development and manufacturing organization (CDMO) headquartered in Arcadia, California, with operations in Seoul, South Korea. Founded in 2019 by engineers with backgrounds at Abbott Vascular and Johnson & Johnson, Nventric designs and builds minimally invasive vascular devices - covering neurovascular, coronary, and electrophysiology applications - from concept through scalable, ISO 13485-certified manufacturing. Its own-branded neurovascular line, including the ULTRIVA stent retriever and EVOGLIDE distal access catheter, targets acute ischemic stroke, while its OEM/CDMO services help device companies move products from prototype to commercialization.

Sungwoo Min is the founder and CEO of Nventric, Inc., an Arcadia, California medical device company that designs, develops, and contract-manufactures vascular devices for the neurovascular, electrophysiology, and coronary markets. A Stanford-trained mechanical engineer who cut his teeth on R&D and marketing at Abbott Vascular and later led R&D programs at Johnson & Johnson, he started Nventric in 2019 to build the kind of life-saving catheters, stents, and thrombectomy systems he used to ship at the giants - this time end to end, ISO 13485 certified, with operations in the US and South Korea. He is a named inventor on multiple US patents for mechanical thrombectomy devices.